Processing of Individual Case Safety Reports in The Pharmacovigiland Department of Indonesian Vaccine Companies
DOI:
https://doi.org/10.58344/jws.v2i3.246Keywords:
business process management, operation management, performance management, pharmacovigilance, vaccineAbstract
This study aimed to determine and analyze the processing design of individual case safety reports in Indonesia's pharmacovigilance department of vaccine companies. This study combines qualitative and quantitative studies that propose implementing the new artificial intelligence system for the PV Department. The results obtained from this study are problem-solving solutions by increasing the number of staff, using artificial intelligence (AI) technology in AEFI case processing to avoid errors and manual input, and approaching external stakeholders to be able to report safety data efficiently and more structured. With the addition of human resources to process the AEFI reporting data by one person, performance value will be increased to 165%. If the process utilizes AI technology, case processing performance increases to 219%. disruption of the performance of the pharmacovigilance department in Indonesian biopharmaceutical companies can be caused by the pandemic disrupting the way KIPI cases are reported, so the solution is the addition of human resources, changes in processes and SOPs, as well as approaches to external stakeholders to streamline case processing.
References
Aradea, A. Y., & Himawan, H. (2013). Kata Kunci: Change Management, Transition Model, Manajemen Proyek dan Perubahan.
Cadle, J., Paul, D., & Turner, P. (2010). Business analysis techniques: 72 essential tools for success. BCS, The Chartered Institute.
Hadinegoro, S. R. S. (2016). Kejadian Ikutan Pasca Imunisasi. Sari Pediatri, 2(1), 2. https://doi.org/10.14238/sp2.1.2000.2-10
Mendling, J., Reijers, H. A., La Rosa, M., & Dumas, M. (2013). Fundamentals of Business Process Management. GI-Jahrestagung, 157.
Nugraha, D., Daningrum, V., Ariyadi, A., & Fiqar, T. P. (2019). Pemodelan Proses Bisnis Penggajian Pada Pt. Bumi Sawindo Permai. JUTI J. Ilm. Teknol. Inf, 17 (1), 12. http://dx.doi.org/10.12962/j24068535.v17i1.a731
Nuraeni Sayuti, N. (2013). Bahan Ajar Analisis Bisnis.
Oracle. (2022). Safety one intake solution brief - Oracle. https://www.oracle.com/a/ocom/docs/industries/life-sciences/safety-one-intake-solution-brief.pdf
Otenyo, E. E. (2023). Chapter 1 - COVID-19 and vaccine nationalism: managing the politics of global pandemics, an introduction (E. E. B. T.-C.-19 and V. N. Otenyo (ed.); pp. 1–35). Academic Press. https://doi.org/10.1016/B978-0-443-18570-0.00005-1
Pelanggan, P. (2013). proses bertujuan untuk mengoptimalkan proses untuk memenuhi kebutuhan organisasi dan. Analisis Siklus Manajemen Proses Bisnis pada PT. Unilever Indonesia Tbk.
Rashin, M. A., & Ghina, A. (2018). Identifikasi Inovasi dan kinerja bisnis dalam meningkatkan daya saing. Jurnal Penelitian Pendidikan, 18 (2), 213–219.
Rosyanti, L., & Hadi, I. (2020). Dampak Psikologis dalam Memberikan Perawatan dan Layanan Kesehatan Pasien COVID-19 pada Tenaga Profesional Kesehatan. Health Information?: Jurnal Penelitian, 12 (1), 107–130. https://doi.org/10.36990/hijp.vi.191
Salas, M., Petracek, J., Yalamanchili, P., Aimer, O., Kasthuril, D., Dhingra, S., Junaid, T., & Bostic, T. (2022). The Use of Artificial Intelligence in Pharmacovigilance: A Systematic Review of the Literature. Pharmaceutical Medicine, 36 (5), 295–306. https://doi.org/10.1007/s40290-022-00441-z
Schmider, J., Kumar, K., LaForest, C., Swankoski, B., Naim, K., & Caubel, P. M. (2019). Innovation in pharmacovigilance: use of artificial intelligence in adverse event case processing. Clinical Pharmacology & Therapeutics, 105 (4), 954–961. https://doi.org/10.1002/cpt.1255
Sugiyanto, E. (2016). Pengendalian Dalam Organisasi.
Wibowo, A. (2021). Manajemen Perubahan (Change Management). Penerbit Yayasan Prima Agus Teknik, 1–180.
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Journal of World Science
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International. that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
